SCHEMBL29664634

SCHEMBL29664634

CNC(=O)C(C)c1ccco1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.46
KMT2A Q03164 4/20 0.46
POLB P06746 3/20 0.46
PTPN1 P18031 2/20 0.46
PKM P14618 1/20 0.46
PTPN7 P35236 1/20 0.46
BLM P54132 1/20 0.46
ESR2 Q92731 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 3/20 0.43
MEN1 O00255 2/20 0.43
MAPT P10636 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
AGTR1 P30556 1/20 0.42
HPGD P15428 1/20 0.41
RAB9A P51151 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4418028 0.83 ALOX5 (0.49) ALOX5KMT2APOLBPTPN1PKM
SCHEMBL27536602 0.79 KMT2A (0.52) ALOX5KMT2APOLBPTPN1PKM
SCHEMBL2480787 0.78 KMT2A (0.61) ALOX5KMT2APOLBPTPN1PKM
SCHEMBL11538261 0.78 KMT2A (0.52) ALOX5KMT2APOLBPTPN1PKM
SCHEMBL5535025 0.77 ALDH1A1 (0.48) ALOX5KMT2APOLBPTPN1PKM
Hydrochloric Acid SCHEMBL9402317 0.76 KMT2A (0.59) ALOX5KMT2APOLBPTPN1PKM
SCHEMBL9402314 0.76 ALOX5 (0.49) ALOX5KMT2APOLBPTPN1PKM
SCHEMBL3577958 0.76 ALOX5 (0.58) ALOX5KMT2APOLBPTPN1PKM
SCHEMBL14899622 0.75 KMT2A (0.44) ALOX5KMT2APOLBPTPN1PKM
Hydrochloric Acid SCHEMBL5352590 0.74 ALOX5 (0.56) ALOX5KMT2APOLBPTPN1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022096679-A1 PROTEIN-PROTEIN INTERACTION MODULATORS OF AURORA KINASE A AND THEIR USE IN THE PREVENTION AND/OR TREATMENT OF CANCER EBERHARD KARLS UNIVERSITÄT TÜBINGEN (DE) 2022-05-12 WO disclosed